UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009265
Receipt number R000008950
Scientific Title The efficacy of azithromycin for the treatment of nonalcoholic steatohepatitis accompanied with Porphyromonas.gingivalis infection in the liver-Randomized controlled trial
Date of disclosure of the study information 2012/11/10
Last modified on 2019/03/07 11:39:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The efficacy of azithromycin for the treatment of nonalcoholic steatohepatitis accompanied with Porphyromonas.gingivalis infection in the liver-Randomized controlled trial

Acronym

The efficacy of azithromycin for the treatment of nonalcoholic steatohepatitis accompanied with Porphyromonas.gingivalis infection in the liver-Randomized controlled trial

Scientific Title

The efficacy of azithromycin for the treatment of nonalcoholic steatohepatitis accompanied with Porphyromonas.gingivalis infection in the liver-Randomized controlled trial

Scientific Title:Acronym

The efficacy of azithromycin for the treatment of nonalcoholic steatohepatitis accompanied with Porphyromonas.gingivalis infection in the liver-Randomized controlled trial

Region

Japan


Condition

Condition

nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Classification by specialty

Hepato-biliary-pancreatic medicine Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To demonstrate the efficacy and safety of azithromycin for the treatment of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis accompanied with Porphyromonas.gingivalis infection in the liver

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase III


Assessment

Primary outcomes

improvement of liver function test

Key secondary outcomes

improvement of histological findings of the liver


Base

Study type

Interventional


Study design

Basic design

Factorial

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

medical drug

Interventions/Control_2

placebo

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1, NAFLD/NASH with P.gingivalis infection in the liver
2, Patients between 20 years old and older than that, and age less than 80 years old.
3, Patients who agreed to participate in this study.

Key exclusion criteria

1, Patients with alcoholic liver diseases.
2,Patients with viral liver diseases, autoimmune hepatitis, and primary biliary cirrhosis.
3, Paitents with pregnancy.
4, Patients who have allergy against ingredients of azithromicin.
5, Patients who have allergy against other macrolides and ketolides.
6, Patients with liver cirrhosis,liver failure including severe liver function test, hepatocellular carcinoma in the liver and other organs.
7, Patients with severe heart diseases.
8, Patients with hereditary fructose intolerance, glucose-galactose malabsorption, and sucrase-isomaltase deficiency.
9, Medical doctors decided the patients inappropriate.

Target sample size

44


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuaki Chayama

Organization

Hiroshima University Hospital

Division name

Gastroenterology and Metabolism

Zip code


Address

1-2-3 Kasumi, Minamiku, Hiroshima, 734-8551, Japan

TEL

082-257-5191

Email



Public contact

Name of contact person

1st name
Middle name
Last name Hideyuki Hyogo

Organization

Hiroshima University Hospital

Division name

Gastroenterology and Metabolism

Zip code


Address


TEL


Homepage URL


Email

hidehyogo@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University Hospital

Institute

Department

Personal name



Funding Source

Organization

self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

広島大学病院(広島県)


Other administrative information

Date of disclosure of the study information

2012 Year 11 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2012 Year 10 Month 01 Day

Date of IRB


Anticipated trial start date

2012 Year 11 Month 10 Day

Last follow-up date

2014 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 11 Month 05 Day

Last modified on

2019 Year 03 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008950


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name